Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3
Hepatology2011Vol. 54(3), pp. 900–909
Citations Over TimeTop 1% of 2011 papers
Abstract
Excessive IL-22 can be found in the HCC microenvironment, leading to tumor growth, inhibition of apoptosis, and promotion of metastasis due to STAT3 activation.
Related Papers
- Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.(2003)
- Spontaneous rupture of hepatocellular carcinoma.(2002)
- Pathology of hepatocellular carcinoma(2006)
- The medical management of hepatocellular carcinoma (HCC) in Japan: a review with implications for HCC seen in the west.(1997)
- Analysis of the influence factors of serum alpha-fetoprotein levels in patients with hepatocellular carcinoma(2001)